Windlas Other Liab from 2010 to 2025
| WINDLAS Stock | 820.65 10.25 1.23% |
Other Liabilities | First Reported 2010-12-31 | Previous Quarter 20.7 M | Current Value 17.8 M | Quarterly Volatility 2.6 M |
Check Windlas Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windlas Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.7 M, Interest Expense of 22.3 M or Selling General Administrative of 30.2 M, as well as many indicators such as . Windlas financial statements analysis is a perfect complement when working with Windlas Biotech Valuation or Volatility modules.
Windlas | Other Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Windlas Stock Analysis
When running Windlas Biotech's price analysis, check to measure Windlas Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windlas Biotech is operating at the current time. Most of Windlas Biotech's value examination focuses on studying past and present price action to predict the probability of Windlas Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windlas Biotech's price. Additionally, you may evaluate how the addition of Windlas Biotech to your portfolios can decrease your overall portfolio volatility.